# Evolent Health, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Evolent Health, Inc.). ## Overview Evolent Health, Inc. is a U.S.-based management services company focused on specialty care management and value-based care enablement for health plans and other risk-bearing healthcare organizations. It uses technology-enabled clinical pathways and administrative services to help customers manage complex, high-cost conditions such as oncology, cardiology, musculoskeletal care, radiology, and genetics. ## Products & services • Specialty Care Management Services • Evidence-based clinical pathway support • Administrative and utilization management services • Value-based care enablement solutions • Identifi® integrated technology platform - **Specialty Care Management Services** (75%) — Core services that manage complex specialty conditions and guide care decisions across oncology, cardiology, musculoskeletal, radiology, and genetics. - **Administrative Services** (15%) — Back-office and operational support services delivered alongside specialty care programs for payer and provider partners. - **Total Cost of Care Management** (5%) — Care management and risk-related services previously associated with Evolent Care Partners and similar arrangements. - **Technology Platform and Implementation Services** (5%) — Identifi® and related implementation, workflow, and integration services that support clinical and administrative operations. - Specialty Care Management Services - Evidence-based clinical pathway support - Administrative and utilization management services - Value-based care enablement solutions - Identifi® integrated technology platform ## Customers Evolent sells primarily to health plans, delegated arrangements, and other risk-bearing entities that want to manage specialty medical spend and improve care quality. It also serves health systems, providers, and physicians that participate in value-based payment models and need clinical decision support and administrative coordination. - **Health plans and payers** (primary) — Buy specialty care management and administrative services to manage high-cost specialty claims and improve member outcomes. - **Risk-bearing entities** (primary) — Use Evolent's programs to align incentives, manage utilization, and reduce avoidable specialty spend. - **Health systems and providers** (secondary) — Adopt value-based care tools and workflow support to participate in alternative payment models. - **Physicians and care teams** (secondary) — Use pathway guidance and integrated technology to support evidence-based treatment decisions. - Health plans buying specialty care management to control medical cost - Risk-bearing entities seeking evidence-based utilization management - Health systems and providers adopting value-based care workflows - Delegated arrangements needing outsourced specialty care operations - Physicians using clinical pathway support and rapid feedback tools ## Geography Evolent's business is concentrated in the United States, and management states that all revenue is recognized in the U.S. and substantially all long-lived assets are located there. The company therefore has limited geographic diversification, and its exposure is tied mainly to U.S. healthcare regulation, payer dynamics, and specialty-care cost trends. - **United States** (100%) — Management states all revenue is recognized in the United States. - All revenue is recognized in the United States - Substantially all long-lived assets are located in the United States - U.S. healthcare regulation is a core operating exposure - Customer demand is tied to U.S. payer and provider markets - No meaningful international revenue disclosure was provided ## Strategy Evolent is repositioning its portfolio toward integrated specialty care management and away from non-core activities, including the sale of Evolent Care Partners. Management is also focused on streamlining operations, migrating acquired businesses onto a common technology platform, and improving profitability while preserving its value-based care positioning. - **Concentrate on specialty care management** (short-term) — This is the company's main revenue source and the clearest fit with its value-based care model. - **Integrate acquisitions onto one platform** (medium-term) — A common technology and operating model should improve scalability and service consistency. - **Improve profitability through simplification** (short-term) — Cost reduction and organizational simplification support sustainable earnings growth. - Focus on specialty care management as the core growth engine - Use integrated clinical and administrative services to reduce vendor fragmentation - Migrate acquired businesses onto the Identifi® platform - Streamline operations and consolidate brands, processes, and office space - Exit non-core assets such as Evolent Care Partners ## Risks Evolent's results are exposed to U.S. healthcare regulation, reimbursement and utilization trends, and the economics of managing specialty claims. The company also faces customer concentration, regulatory/investigative risk, and execution risk as it integrates acquisitions and manages medical claims cost volatility. - **Medical claims cost inflation** [high] — Higher disease prevalence and higher cost per active patient can increase service costs faster than pricing. - **Customer concentration** [high] — A small number of payers represent a large share of revenue, so contract changes can materially affect results. - **Healthcare regulatory and political change** [medium] — Changes in federal and state healthcare rules can alter reimbursement, compliance costs, and service design. - **False Claims Act / Anti-Kickback investigations** [high] — Coding, review, and claims practices can be challenged by regulators and create legal liabilities. - **Acquisition integration and restructuring execution** [medium] — The business depends on consolidating acquired operations and technology without disrupting service delivery. - Customer concentration can swing revenue when large payer contracts change - Medical claims cost inflation can pressure margins in performance-based programs - Healthcare regulation and payment policy may change operating economics - False Claims Act and Anti-Kickback exposure can create legal and reputational risk - Integration and restructuring execution risk can disrupt service quality and savings ## Accounting Revenue is recognized entirely in the United States, but the more important accounting issues are judgment around claims-related costs, customer concentration disclosures, and goodwill impairment. Management also highlights goodwill testing and restructuring charges, both of which can materially affect reported earnings when assumptions change or integration costs are incurred. - **Goodwill impairment** — Could create large non-cash charges if reporting unit value declines - **Medical claims cost estimates** — Affects revenue-to-cost matching and operating margin - **Restructuring and repositioning costs** — Creates period-to-period comparability noise in SG&A - **Discontinued or sold operations** — May affect segment-like trend analysis and cost base - Goodwill impairment testing depends on management's fair value assumptions - Claims cost estimates affect margins in performance-based specialty programs - Restructuring charges from repositioning plans affect comparability across periods - Customer concentration disclosures show revenue dependence on a few large partners - Disposal accounting may affect comparability after the Evolent Care Partners sale --- *Last updated: 2026-04-28T20:05:40.765410+00:00*